Skip to content

Drug interactions

Ponatinib + Posaconazole

Severity: Major

Ponatinib and Posaconazole: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ponatinib is a CYP3A4 substrate, so posaconazole may raise its exposure. This increases the risk of serious adverse effects such as arterial occlusion, hepatotoxicity, pancreatitis and heart failure.

What this interaction means in plain words

Ponatinib and Posaconazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Ponatinib belongs to Oncology; Posaconazole belongs to Anti Fungals.

Evidence level: Moderate

Why it happens

Posaconazole inhibits CYP3A4 metabolism of ponatinib.

What to do

Avoid the combination if possible. If unavoidable, reduce the ponatinib dose per labeling and monitor for cardiovascular and hepatic toxicity.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Ponatinib and Posaconazole, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Ponatinib with Posaconazole?

MediHelp rates the interaction as major. Ponatinib and Posaconazole can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Ponatinib is a CYP3A4 substrate, so posaconazole may raise its exposure. This increases the risk of serious adverse effects such as arterial occlusion, hepatotoxicity, pancreatitis and heart failure.

How serious is the interaction between Ponatinib and Posaconazole?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination if possible. If unavoidable, reduce the ponatinib dose per labeling and monitor for cardiovascular and hepatic toxicity.

What other medicines interact with Posaconazole?

MediHelp also lists interactions of Posaconazole with, for example, Artemether, Avanafil, Cobimetinib. The full list is on the Posaconazole page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in